Cis double PIK3CA mutations are common in cancers and increase sensitivity to PI3Kα inhibitors. ©2019 American Association for Cancer Research.
PIK3CA Double Mutations in Cis May Predict PI3Kα-Inhibitor Response. Cancer discovery. 2020 Jan;10(1):OF6
PMID: 34365394
View Full Text